{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:59:19Z","timestamp":1790488759016,"version":"4.1.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["15SANIN211"],"award-info":[{"award-number":["15SANIN211"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Artesunate-amodiaquine is a potential therapy for uncomplicated malaria in Cambodia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Between September 2016 and January 2017, artesunate-amodiaquine efficacy and safety were evaluated in a prospective, open-label, single-arm observational study at health centers in Mondulkiri, Pursat, and Siem Reap Provinces, Cambodia. Adults and children with microscopically confirmed Plasmodium falciparum malaria received oral artesunate-amodiaquine once daily for 3 days plus single-dose primaquine, with follow-up on days 7, 14, 21, and 28. The primary outcome was day-28 polymerase chain reaction (PCR)-adjusted adequate clinical and parasitological response (ACPR). An amodiaquine parasite survival assay (AQSA) was developed and applied to whole genome sequencing results to evaluate potential amodiaquine resistance molecular markers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In 63 patients, day-28 PCR-adjusted ACPR was 81.0% (95% confidence interval [CI], 68.9\u201388.7). Day 3 parasite positivity rate was 44.4% (28\/63; 95% CI, 31.9\u201357.5). All 63 isolates had the K13(C580Y) marker for artemisinin resistance; 79.4% (50\/63) had Pfpm2 amplification. The AQSA resistance phenotype (\u226545% parasite survival) was expressed in 36.5% (23\/63) of isolates and was significantly associated with treatment failure (P\u2005=\u2005.0020). Pfmdr1 mutant haplotypes were N86\/184F\/D1246, and Pfcrt was CVIET or CVIDT at positions 72\u201376. Additional Pfcrt mutations were not associated with amodiaquine resistance, but the G353V mutant allele was associated with ACPR compared to Pfmdr1 haplotypes harboring F1068L or S784L\/R945P mutations (P\u2005=\u2005.030 and P\u2005=\u2005.0004, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>For uncomplicated falciparum malaria in Cambodia, artesunate-amodiaquine had inadequate efficacy owing to amodiaquine-resistant P. falciparum. Amodiaquine resistance was not associated with previously identified molecular markers.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciaa628","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T11:07:44Z","timestamp":1590404864000},"page":"406-413","source":"Crossref","is-referenced-by-count":55,"title":["Clinical and In Vitro Resistance of <i>Plasmodium falciparum<\/i> to Artesunate-Amodiaquine in Cambodia"],"prefix":"10.1093","volume":"73","author":[{"given":"Melissa","family":"Mairet-Khedim","sequence":"first","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia"},{"name":"Malaria Translational Research Unit, Institut Pasteur, Paris, France"},{"name":"Center for Pathophysiology Toulouse-Purpan (CPTP), INSERM, CNRS, University of Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rithea","family":"Leang","sequence":"additional","affiliation":[{"name":"National Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Marmai","sequence":"additional","affiliation":[{"name":"INSERM 1016, Institut Cochin, Universit\u00e9 of Paris, Paris, France"},{"name":"Service de Parasitologie-Mycologie, H\u00f4pital Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimol","family":"Khim","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia"},{"name":"Malaria Translational Research Unit, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saorin","family":"Kim","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia"},{"name":"Malaria Translational Research Unit, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopheakvatey","family":"Ke","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia"},{"name":"Malaria Translational Research Unit, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chhayleang","family":"Kauy","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia"},{"name":"Malaria Translational Research Unit, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimol","family":"Kloeung","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia"},{"name":"Malaria Translational Research Unit, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rotha","family":"Eam","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia"},{"name":"Malaria Translational Research Unit, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophy","family":"Chy","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia"},{"name":"Malaria Translational Research Unit, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Izac","sequence":"additional","affiliation":[{"name":"INSERM 1016, Institut Cochin, Universit\u00e9 of Paris, Paris, France"},{"name":"Service de Parasitologie-Mycologie, H\u00f4pital Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Mey Bouth","sequence":"additional","affiliation":[{"name":"World Health Organization, Phnom Penh, Cambodia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dorina Bustos","sequence":"additional","affiliation":[{"name":"World Health Organization, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Ringwald","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Ariey","sequence":"additional","affiliation":[{"name":"INSERM 1016, Institut Cochin, Universit\u00e9 of Paris, Paris, France"},{"name":"Service de Parasitologie-Mycologie, H\u00f4pital Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Witkowski","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia"},{"name":"Malaria Translational Research Unit, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"2021080205004646100_CIT0001","author":"World Health Organization","year":"2018"},{"key":"2021080205004646100_CIT0002","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of artemisinin-resistant malaria in western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N Engl J Med"},{"key":"2021080205004646100_CIT0003","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ng.2624","article-title":"Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia","volume":"45","author":"Miotto","year":"2013","journal-title":"Nat Genet"},{"key":"2021080205004646100_CIT0004","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","article-title":"Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies","volume":"13","author":"Witkowski","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2021080205004646100_CIT0005","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1128\/AAC.01868-12","article-title":"Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia","volume":"57","author":"Witkowski","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080205004646100_CIT0006","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4269\/ajtmh.16-0234","article-title":"Plasmodium falciparum resistance to artemisinin derivatives and piperaquine: a major challenge for malaria elimination in Cambodia","volume":"95","author":"Duru","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"2021080205004646100_CIT0007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2875-8-10","article-title":"Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia","volume":"8","author":"Rogers","year":"2009","journal-title":"Malar J"},{"key":"2021080205004646100_CIT0008","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1365-3156.2006.01739.x","article-title":"Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia","volume":"11","author":"Denis","year":"2006","journal-title":"Trop Med Int Health"},{"key":"2021080205004646100_CIT0009","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.00875-06","article-title":"Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria","volume":"51","author":"Humphreys","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080205004646100_CIT0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s12936-016-1598-6","article-title":"Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the tracking resistance to artemisinin collaboration","volume":"15","author":"Srimuang","year":"2016","journal-title":"Malar J"},{"key":"2021080205004646100_CIT0011","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13000-015-0276-2","article-title":"Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine","volume":"10","author":"Oladipo","year":"2015","journal-title":"Diagn Pathol"},{"key":"2021080205004646100_CIT0012","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat Commun"},{"key":"2021080205004646100_CIT0013","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1126\/science.1074045","article-title":"Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations","volume":"298","author":"Sidhu","year":"2002","journal-title":"Science"},{"key":"2021080205004646100_CIT0014","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1128\/AAC.00358-10","article-title":"Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76","volume":"54","author":"Beshir","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080205004646100_CIT0015","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-3156.2009.02269.x","article-title":"Open label randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in central Vietnam","volume":"14","author":"Thanh","year":"2009","journal-title":"Trop Med Int Health"},{"key":"2021080205004646100_CIT0016","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1475-2875-11-217","article-title":"The efficacy and tolerability of artemisinin-piperaquine (Artequick\u00ae) versus artesunate-amodiaquine (Coarsucam\u2122) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam","volume":"11","author":"Thanh","year":"2012","journal-title":"Malar J"},{"key":"2021080205004646100_CIT0017","author":"World Health Organization","year":"2009"},{"key":"2021080205004646100_CIT0018","author":"World Health Organization","year":"2008"},{"key":"2021080205004646100_CIT0019","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"2021080205004646100_CIT0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","article-title":"A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study","volume":"17","author":"Witkowski","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2021080205004646100_CIT0021","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12916-015-0539-5","article-title":"Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations","volume":"13","author":"Duru","year":"2015","journal-title":"BMC Med"},{"key":"2021080205004646100_CIT0022","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S1473-3099(17)30635-7","article-title":"Emergence of Plasmodium falciparum triple mutant in Cambodia","volume":"17","author":"Rossi","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2021080205004646100_CIT0023","first-page":"e01273","article-title":"Pyronaridine-artesunate plus single-dose primaquine efficacy and safety for the treatment of malaria in western Cambodia","volume":"63","author":"Leang","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080205004646100_CIT0024","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/cid\/ciz580","article-title":"Pyronaridine-artesunate efficacy and safety in uncomplicated Plasmodium falciparum malaria in areas of artemisinin-resistant falciparum in Viet Nam (2017\u20132018)","volume":"70","author":"Bui Quang","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021080205004646100_CIT0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s12936-017-2024-4","article-title":"Prevalence of K13 mutation and Day-3 positive parasitaemia in artemisinin-resistant malaria endemic area of Cambodia: a cross-sectional study","volume":"16","author":"Kheang","year":"2017","journal-title":"Malar J"},{"key":"2021080205004646100_CIT0026","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4269\/ajtmh.2007.76.20","article-title":"Molecular epidemiology of malaria in Cameroon. XXIV. Trends of in vitro antimalarial drug responses in Yaounde, Cameroon","volume":"76","author":"Basco","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"2021080205004646100_CIT0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2011.03.003","article-title":"Plasmodium falciparum resistance to cytocidal versus cytostatic effects of chloroquine","volume":"178","author":"Paguio","year":"2011","journal-title":"Mol Biochem Parasitol"},{"key":"2021080205004646100_CIT0028","doi-asserted-by":"crossref","first-page":"e000999","DOI":"10.1136\/bmjgh-2018-000999","article-title":"Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa","volume":"3","author":"Okell","year":"2018","journal-title":"BMJ Glob Health"},{"key":"2021080205004646100_CIT0029","author":"University of Oxford","year":"2019"},{"key":"2021080205004646100_CIT0030","article-title":"Global spread of mutant PfCRT and its pleiotropic impact on Plasmodium falciparum multidrug resistance and fitness","volume":"10:e02731\u201318","author":"Dhingra","year":"2019","journal-title":"MBio"},{"key":"2021080205004646100_CIT0031","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","article-title":"Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine","volume":"91","author":"Venkatesan","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"2021080205004646100_CIT0032","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1038\/s41467-018-05652-0","article-title":"Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine","volume":"9","author":"Ross","year":"2018","journal-title":"Nat Commun"},{"key":"2021080205004646100_CIT0033","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S1473-3099(19)30543-2","article-title":"Plasmodium falciparum resistance to piperaquine driven by PfCRT","volume":"19","author":"Dhingra","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021080205004646100_CIT0034","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021080205004646100_CIT0035","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","article-title":"Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study","volume":"19","author":"Hamilton","year":"2019","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa628\/34862414\/ciaa628.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/3\/406\/39508103\/ciaa628.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/3\/406\/39508103\/ciaa628.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T05:02:20Z","timestamp":1627880540000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/3\/406\/5847731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,5,27]]},"published-print":{"date-parts":[[2021,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa628","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2020,5,27]]}}}